Tax Cuts To Increase Debt And Share Buybacks, Not Jobs
Nov 29, 2017Jeremy Parkinson0
The president has held fast to his pledge even as top executives’ comments have run counter to it for months. Instead of hiring more workers or raising their pay, many companies say they’ll first increase dividends or buy back their own shares.See Trump’s tax promises undercut by CEO’s plans to reward shareholders. The last thing the […]
Bitcoin The False God
Nov 29, 2017Jeremy Parkinson0
Some folks did not take Jack Bogle’s advice. On Tuesday, the father of indexing delivered a pretty straightforward assessment of Bitcoin. “There is nothing to support bitcoin except the hope that you will sell it to someone for more than you paid for it,” Bogle said, in response to a question at at a Council on Foreign Relations […]
WTI Crude Oil And Natural Gas Forecast – Wednesday, November 29
Nov 29, 2017Jeremy Parkinson0
WTI Crude Oil With today being the Crude Oil Inventories announcement in the United States, likely that we will see a significant amount of volatility. We had initially fallen on Tuesday, but turned around to form a bit of a hammer. A break above the top of the candle for the day should send this […]
Growth Alert: New Home Sales Hit 10-year High
Nov 29, 2017Jeremy Parkinson0
Sales of new single-family homes surprised economists in October to the upside. Sales rose last month hitting their highest level in 10 years amid robust demand across the country. The Commerce Department said new home sales increased by 6.2 percent to a seasonally adjusted annual rate of 685,000 units. That was the highest level since […]
Second Estimate 3Q2017 GDP Growth Improves To 3.3 %
Nov 29, 2017Jeremy Parkinson0
The headline second estimate of third quarter 2017 Real Gross Domestic Product (GDP) was increased to a positive 3.3 % from the advance estimate’s 3.0 %. Year-over-year growth was unchanged from the advance estimate. Analyst Opinion of GDP The consumer spending declined, but the real improvement came from fixed investment. I am not a fan of quarter-over-quarter […]
Q3 GDP Revised Up To 3.3%, Highest In 3 Years
Nov 29, 2017Jeremy Parkinson0
After the BEA estimated that US GDP rose an already impressive 3.0% in Q3, moments ago the Department of Commerce revised its estimate for third-quarter growth to 3.3% annualized, higher than the 3.2% print expected, the highest since the third quarter of 2014. On a Y/Y basis, GDP rose by 2.3%, the highest since Q3 2015: […]
German Inflation Beats Expectations With 1.8% Y/y – EUR/USD Ignores
Nov 29, 2017Jeremy Parkinson0
A better than expected inflation read from Germany: annual inflation is now 1.8%, a jump from 1.5% in October. Month over month, prices are up 0.3%. We have the same numbers in both the national and HICP measures. EUR/USD is not really enjoying it, extending the slide and reaching 1.1835. Germany was expected to report a […]
Bull Of The Day: Analog Devices (ADI) – Wednesday, Nov. 29
Nov 29, 2017Jeremy Parkinson0
Video length: 00:00:35 Founded in 1965 and headquartered in Norwood, Massachusetts, Analog Devices (ADI) is an original equipment manufacturer of semiconductor devices, specifically, analog, mixed signal and digital signal processing (DSP) integrated circuits. The company’s products include data converters, amplifiers and linear products, radio frequency integrated circuits, power management products, and sensors and processing products. Solid Quarterly […]
USD/JPY Higher Despite NK Missile Launch
Nov 29, 2017Jeremy Parkinson0
The US Dollar was steady versus the Japanese Yen, receiving support from the latest economic data out of the United States which was unexpectedly upbeat. The Dollar was also resilient in spite of the latest war mongering efforts from North Korea who launched yet another rocket test near Japan. Analysts say that market players are still […]
Allergan Upgraded To Overweight Amid ‘Overdone’ Botox Fears At Morgan Stanley
Nov 29, 2017Jeremy Parkinson0
As previously reported, Morgan Stanley analyst David Risinger upgraded Allergan (AGN) to Overweight from Equal Weight, saying that fears about a “better Botox” from Revance (RVNC) may be overdone. Noting that data about Revance’s botulinum toxin RT002 Phase 3 trial is expected “any day now,” Risinger said he thinks it could be difficult for Revance […]